CONNECT WITH US:
Dec 17, 2018 09:00 JST
Novotech CRO Launches Largest Oracle Trial Management and Monitoring Cloud Service Implementation in Asia-Pacific
SYDNEY, Dec 17, 2018 - (ACN Newswire) - Asia-Pacific specialist CRO Novotech announced as part of its ongoing IT infrastructure investment program that it has implemented the Oracle's Trial Management and Monitoring Cloud Service (TMMCS) to support its growth in the Asia-Pacific.
StemLab CEO Donghoon Oh (Left) and Novotech CEO Dr John Moller (centre) at a recent client presentation in Asia-Pacific.
Oracle Health Sciences VP of Services, David Tuckfield said Novotech will have the largest TMMCS implementation in the Asia-Pacific and is the first biotech-focused CRO in the region to go-live on Oracle's TMMCS technology in the cloud.
"We are delighted to be able to implement Novotech's vision of next generation trial management," he added.
Novotech, the recipient of the 2018 Frost & Sullivan Asia-Pacific Biotech CRO Company of the Year award for the 3rd consecutive year, has been operating in the Asia-Pacific for 22 years.
Novotech CEO Dr John Moller said Novotech has always invested heavily in the latest technology. This ensures regulatory compliance, allows integration into global studies, and gives Novotech teams and clients better data visibility to improve decision-making.
"Oracle's cloud technology provides a centralized trial database enabling improved access, control and governance of clinical data. The system is highly configurable allowing us to tailor process flows and alerts to client needs, as well as ensuring effective control on deviations. Advanced functionalities like eSignatures, and tools for swift approvals and submissions help us accelerate trial implementation."
Novotech launched the migration project in partnership with Oracle Health Science Global Services in March 2018. Novotech has also invested in Oracle Argus for Medical Safety and Oracle Inform EDC.
Novotech is a full service CRO with on-the-ground operations in Australia, New Zealand, South Korea, China, Taiwan, Philippines, Hong Kong, Singapore, Malaysia, Thailand and India with 550+ full-time employees.
Novotech clinical staff numbers have grown by more than 20% in Asia over the last quarter, fueled by demand for a regional CRO with international accreditation and reputation, combined with local knowledge, partnerships and expertise.
The CRO has extensive therapeutic area experience handling clinical studies with small and mid-size biotechnology companies across all phases of clinical trials - First-in-Human (FIH) studies to phase IV. Novotech has managed around 700 projects including the APAC component of pivotal trials for multiple FDA, EMA registered products since 2001
Novotech has now signed 10 strategic collaborations with hospitals and research institutions in the Asia-Pacific region.
About Oracle TMMCS
Oracle Health Sciences Trial Management and Monitoring Cloud Service, enables effective management of critical clinical trial activities and improved relationships with investigators, from early to late-stage clinical trials. With real-time visibility into clinical trial progress and significant utilization rates of clinic and staff resources, this solution can help to lower costs, while increasing study speed and data quality. These services are part of the foundation for Oracle Health Sciences' integrated, holistic approach to risk-based monitoring.
About Novotech -
Headquartered in Sydney, Novotech is internationally recognized as the leading regional full-service contract research organization (CRO). With a focus on clinical monitoring, Novotech has been instrumental in the success of hundreds of Phase I - IV clinical trials in the Asia Pacific region.
Novotech provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services, central lab services, report write-up to ICH requirements, project and vendor management. Novotech's strong Asia Pacific presence includes running clinical trials in all key regional markets. Novotech also has worldwide reach through the company's network of strategic partners.
For Media enquiries:
Susan Fitzpatrick-Napier, AU: +61 2 8218 2144
USA: +1 415 951 3228, Asia: +65 3159 3427
Copyright ©2020 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Fujitsu Launches 14 New Models of Enterprise Notebooks, Tablets and Workstations Optimized for Remote Work
May 26, 2020 11:10 JST
Fujitsu Develops AI-Video Recognition Technology to Promote Hand Washing Etiquette and Hygiene in the Workplace
May 26, 2020 10:34 JST
Mitsubishi Motors Joins OPEN COVID-19 DECLARATION
May 26, 2020 09:34 JST
Tokyo Metropolitan Government to trial 5G Antenna-equipped Smart Poles in Cooperation with Sumitomo Corporation and NEC
May 25, 2020 10:44 JST
Mazda Begins Providing, Virtual Racing Car, Mazda RX-Vision GT3 Concept Online
May 22, 2020 14:26 JST
'e5 Consortium' Established to Promote Zero-Emission Electric Vessel
May 21, 2020 15:34 JST
TOYOTA GAZOO Racing Decides Not to Participate in 2020 Edition of Nurburgring 24 Hours
May 21, 2020 14:19 JST
Fujitsu RunMyProcess Drives Next Phase of Digital Transformation in Business Processes with DigitalSuite ProcessModeler
May 21, 2020 09:00 JST
MHPS Captures Global Gas Turbine Market Share Leadership Again
May 20, 2020 10:09 JST
Hitachi Awarded Contract to Supply, Install 300 Lifts at HDB Blocks in Singapore
May 19, 2020 11:57 JST
DENSO, Global Mobility Service to Support Delivery of COVID-19 Test Kits in Indonesia
May 18, 2020 17:36 JST
Eisai to Launch New Selbelle Premium Tablets and New Selbelle Premium Fine Granules
May 18, 2020 13:33 JST
Hitachi to Provide $1 Million in Loans through Kiva to Businesses in Need around the Globe, Affected by the Spread of the COVID-19
May 18, 2020 13:24 JST
Toyota's Adjustments to Domestic Production in June 2020 (as of May 15)
May 15, 2020 17:01 JST
Transgene and NEC Demonstrate High Accuracy of AI-based Neoantigen Prediction for the Design of Individualized Cancer Vaccine TG4050
May 15, 2020 14:10 JST
Fujitsu and Accenture Collaboration Accelerates Reliable Blockchain Interoperability
May 15, 2020 10:11 JST
Mazda Releases FY March 2020 Full Year Financial Results
May 14, 2020 17:01 JST
Fujitsu Sets Out the 'Fujitsu Technology and Service Vision 2020'
May 14, 2020 15:53 JST
Notice of Agreement for the Merger through Absorption (Simplified Absorption-type Merger) of a Consolidated Subsidiary of Fujitsu Limited
May 14, 2020 15:46 JST
Eisai to Present Data on Oncology Pipeline and Products at ASCO20 Annual Meeting
May 14, 2020 09:22 JST
More Latest Release >>
Novotech Selected as CRO for Karyopharm's COVID-19 Clinical Study
April 29 2020 21:00 JST
Novotech COVID-19 Clinical Trial Clients Benefit from New Asia-Pacific Fast-Track Review Processes
April 28 2020 19:00 JST
Novotech Data Shows Majority of Australian Sites are Open for Clinical Trial Activity
April 08 2020 18:00 JST
Novotech CRO Tapped for Two Informa Citeline Awards for Excellence in Asia-Pacific Clinical Trials
March 20 2020 20:30 JST
Novotech Wins CRO Contract for Komipharm Coronavirus Covid-19 Clinical Trial in South Korea
March 06 2020 22:00 JST
Asia-Pacific has Record Year for Clinical Trials says Novotech CRO
January 21 2020 10:40 JST
Novotech CRO partners Skin Research Institute of Singapore (SRIS) for Skin Disorder Research
July 11 2019 11:00 JST
Novotech Awarded Asia-Pacific Biotech CRO of the Year - Announced at ASCO
May 31 2019 07:00 JST
Novotech CRO strengthens South Korean Clinical Capabilities, partners with 2 Major Hospitals
April 18 2019 04:00 JST
Novotech CNS USA Appoints Dr Robert Malone to its Washington, DC BioDesk
March 25 2019 18:00 JST
More Press release >>